is semaglutide oral effective Semaglutide, the First Ingestible Glucagon-Like Peptide-1 Receptor Agonist: Could It Be a Magic Bullet for Type 2 Diabetes? Weight loss medications have been

New research suggests that stopping GLP-1 drugs may raise risks of heart attack and stroke, complicating the booming weight loss trend.

Clinical studies have reported changes in metabolic markers such as lipid concentrations, glucose biomarkers, and blood pressure measurements when the compound is examined in controlled research settings

PlexusDx explains the science behind combining medication with movement for optimal outcomes

Dual GIP/GLP-1 for superior weight loss when semaglutide isn't enough

As expected for the GLP-1 receptor agonist class, the most common adverse events were gastrointestinal, and no new safety signals were identified

Recognize gastroparesis symptoms early to prevent complications